NCT03762811View on ClinicalTrials.gov

Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Bone; Degeneration
Interventions
DEVICE

NanoFUSE® Bioactive Matrix

NanoFUSE® is placed into bony voids or gaps of the skeletal system that are not intrinsic to the stability of the bony structure.

Sponsors
All Listed Sponsors
lead

NanoFUSE Biologics, LLC

INDUSTRY